Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

PHARMACEUTICAL BENEFITS WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

Nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.

The pharmaceutical benefits listed for prescribing by authorised nurse practitioners are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not issue PBS prescriptions for pharmaceutical benefits that do not specify ‘NP’ in the listing.

PBS prescribing is limited by a nurse practitioner’s scope of practice, adherence to professional practice standards as set by the Nursing and Midwifery Board of Australia, and state or territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner as required by the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health and Aged Care regarding which medicines will attract a PBS subsidy when prescribed by authorised nurse practitioners.

Further to prescribing within an individual’s scope of practice, certain medicines have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. Authorised nurse practitioners should check the details of individual pharmaceutical benefits listings to ensure that all specified circumstances are met.

Some medicines are included in more than one section of the Schedule and for more than one prescriber type. For a prescription to be eligible for subsidy, authorised nurse practitioners must ensure that they prescribe under the PBS listing that specifies ‘NP’, and in accordance with any restrictions specified in that listing. Listing details for the same product may differ between sections of the Schedule and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms. Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as non-PBS (private) prescriptions provided that any prescribing is within the individual nurse practitioner’s scope of practice and any limitations declared through state or territory law. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to state/territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • NPNurse Practitioner
  • OPOptometrist
  • 60D60-day prescriptions
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 12519X HALOPERIDOLhaloperidol 5 mg/mL injection, 10 x 1 mL ampoules 1 10 2
MPNP 2768Q HALOPERIDOLhaloperidol 5 mg/mL injection, 10 x 1 mL ampoules 1 10 0
MPNP 3456X HALOPERIDOLhaloperidol 5 mg/mL injection, 10 x 1 mL ampoules 1 10 0
MPNP 2763K HALOPERIDOLhaloperidol 2 mg/mL oral liquid, 100 mL 1 1 5
MPNP 2767P HALOPERIDOLhaloperidol 1.5 mg tablet, 100 1 100 5
MPNP 2770T HALOPERIDOLhaloperidol 5 mg tablet, 50 1 50 5
MPNP 2761H HALOPERIDOLhaloperidol 500 microgram tablet, 100 1 100 5
MPNP 2766N HALOPERIDOL DECANOATEhaloperidol (as decanoate) 150 mg/3 mL injection, 5 x 3 mL ampoules 1 5 0
MPNP 2765M HALOPERIDOL DECANOATEhaloperidol (as decanoate) 50 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 1466E HEPARINheparin sodium 5000 units/0.2 mL injection, 5 x 0.2 mL ampoules 1 5 5
MPNP 2652N HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (3:1 ratio long chain fat to carbohydrate plus protein) powder for oral liquid, 300 g 24 24 5
MPNP 10185C HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio long chain fat to carbohydrate plus protein) oral liquid, 32 x 200 mL cartons 5 5 5
MPNP 12635B HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate oral semi-solid, 36 x 100 g tubs 4 4 5
MPNP 9446E HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio long chain fat to carbohydate plus protein) powder for oral liquid, 300 g 24 24 5
MPNP 12456N HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 30 x 250 mL cartons 6 6 5
MPNP 12789D HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 30 x 250 mL cartons 6 6 5
MPNP 12464B HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (3:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 30 x 250 mL cartons 6 6 5
MPNPOP 14354L HYALURONATE SODIUMhyaluronate sodium 0.1% eye drops, 10 mL 2 2 5
MPNP 2181T HYALURONATE SODIUMhyaluronate sodium 0.1% eye drops, 10 mL 1 1 5
MPNPOP 14494W HYALURONATE SODIUMhyaluronate sodium 0.2% eye drops, 10 mL 2 2 5
MPNP 2253N HYALURONATE SODIUMhyaluronate sodium 0.2% eye drops, 10 mL 1 1 5
MPNP 13409R HYDROCHLOROTHIAZIDEhydrochlorothiazide 25 mg tablet, 100 2 200 1
MPNP 1484D HYDROCHLOROTHIAZIDEhydrochlorothiazide 25 mg tablet, 100 1 100 1
MPNP 14476X HYDROCORTISONEhydrocortisone 20 mg tablet, 60 2 120 4
MPNP 1500Y HYDROCORTISONEhydrocortisone 20 mg tablet, 60 1 60 4
MPNP 13863P HYDROCORTISONEhydrocortisone 4 mg tablet, 50 2 100 4
MPNP 1499X HYDROCORTISONEhydrocortisone 4 mg tablet, 50 1 50 4
MPNP 1502C HYDROCORTISONE ACETATEhydrocortisone acetate 10% enema, 21.1 g 2 2 3
MPNP 2881P HYDROCORTISONE ACETATEhydrocortisone acetate 1% cream, 50 g 1 1 1
MPNP 2441L HYDROCORTISONE ACETATEhydrocortisone acetate 1% eye ointment, 5 g 1 1 0
MPNP 2882Q HYDROCORTISONE ACETATEhydrocortisone acetate 1% ointment, 50 g 1 1 1
MPNP 1501B HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 100 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 2 2 0
MPNP 1510L HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 100 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 6 6 0
MPNP 3470P HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 100 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 2 2 0
MPNP 1511M HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 250 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 6 6 0
MPNP 3096Y HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 250 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 1 1 0
MPNP 3471Q HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 250 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 1 1 0
MPNP 14076W HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 500 mL 1 500 0
MPNP 14084G HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 500 mL 1 500 1
MPNP 12531M HYDROMORPHONEhydromorphone hydrochloride 10 mg/mL injection, 5 x 1 mL ampoules 2 10 1
MPNP 8421F HYDROMORPHONEhydromorphone hydrochloride 10 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 12493M HYDROMORPHONEhydromorphone hydrochloride 2 mg/mL injection, 5 x 1 mL ampoules 2 10 1
MPNP 8420E HYDROMORPHONEhydromorphone hydrochloride 2 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 12565H HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL 1 473 1
MPNP 12582F HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL 1 473 0
MPNP 13796D HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL 1 473 0
MPNP 13806P HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL 1 473 1
MPNP 12047C HYDROMORPHONEhydromorphone hydrochloride 2 mg tablet, 20 0.5 10 0
MPNP 12497R HYDROMORPHONEhydromorphone hydrochloride 2 mg tablet, 20 2 40 1
MPNP 8541M HYDROMORPHONEhydromorphone hydrochloride 2 mg tablet, 20 1 20 0
MPNP 12046B HYDROMORPHONEhydromorphone hydrochloride 4 mg tablet, 20 0.5 10 0
MPNP 12484C HYDROMORPHONEhydromorphone hydrochloride 4 mg tablet, 20 2 40 1
MPNP 8542N HYDROMORPHONEhydromorphone hydrochloride 4 mg tablet, 20 1 20 0
MPNP 12016K HYDROMORPHONEhydromorphone hydrochloride 8 mg tablet, 20 0.5 10 0
MPNP 12515Q HYDROMORPHONEhydromorphone hydrochloride 8 mg tablet, 20 2 40 1
MPNP 8543P HYDROMORPHONEhydromorphone hydrochloride 8 mg tablet, 20 1 20 0
MPNP 2162T HYDROXOCOBALAMINhydroxocobalamin 1 mg/mL injection, 3 x 1 mL ampoules 1 3 0
MPNP 9048F HYDROXOCOBALAMINhydroxocobalamin 1 mg/mL injection, 3 x 1 mL ampoules 1 3 0
MPNP 1512N HYDROXYCHLOROQUINEhydroxychloroquine sulfate 200 mg tablet, 100 1 100 1
MPNP 9487H HYDROXYETHYL STARCH 130/0.4 + SODIUM CHLORIDEHYDROXYETHYL STARCH 130/0.4 I.V. infusion 30 g per 500 mL, 500 mL, 1 3 3 0
MPNP 3473T HYOSCINE BUTYLBROMIDEhyoscine butylbromide 20 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 5317W HYOSCINE BUTYLBROMIDEhyoscine butylbromide 20 mg/mL injection, 5 x 1 mL ampoules 6 30 3
MPNP 11625W HYPROMELLOSEhypromellose 0.3% w/w eye drops, 10 mL 1 1 5
MPNPOP 14318N HYPROMELLOSEhypromellose 0.3% w/w eye drops, 10 mL 2 2 5
MPNP 11842G HYPROMELLOSEhypromellose 0.3% w/v eye drops, 10 mL 1 1 5
MPNPOP 14492R HYPROMELLOSEhypromellose 0.3% w/v eye drops, 10 mL 2 2 5
MPNPOP 14320Q HYPROMELLOSEhypromellose 0.5% eye drops, 15 mL 2 2 5
MPNP 2956N HYPROMELLOSEhypromellose 0.5% eye drops, 15 mL 1 1 5
MPNP 8564R HYPROMELLOSE + CARBOMER-980hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g 1 1 5